Senior insider sale
EVP, General Counsel at KRYSTAL BIOTECH, INC. — senior position signals high conviction
$193.9K
642.00 shares
What this filing means
THOMAS JOHN CHARLES plans to sell 642.00 shares of KRYSTAL BIOTECH, INC. valued at approximately $193.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/26/2026ACC: 0001959173-26-003960
Officer· EVP, General Counsel
Since Mar 2026
642.00
Shares to sell
$193.9K
Approx. market value
642.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/27/2026
642.00Total acquired642.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/27/2026 | Restricted Stock Vesting Compensation | 642.00 | — |
| Total | 642.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
642.00
Market value
$193.9K
5/26/2026
Total
Units
642.00
Value
$193.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/26/2026 | 642.00 | $193.9K | NASDAQ | Planned |
| Total | 642.00 | $193.9K | ||